Why Synergy Pharmaceuticals (SGYP) Stock Is Surging This Morning

NEW YORK (TheStreet) -- Shares of Synergy Pharmaceuticals Inc. (SGYP) are up 8.51% to $5.23 in pre-market trade after the company announced that its experimental constipation drug met the main goal of a mid-stage study in patients with a form of irritable bowel syndrome, Reuters reports.

The trial tested four doses of the drug in patients with irritable bowel syndrome with constipation, and the company said it selected a 3 mg dose to be tested in late-stage studies in the second half of the year.

Synergy said the drug was safe and well tolerated in the study, with no serious adverse events related to the treatment.

Must Read: Warren Buffett's 10 Favorite Growth Stocks

SGYP Chart

SGYP data by YCharts

STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months.Learn more.

More from Markets

5 Stocks That Are Screaming Buys Right Now

5 Stocks That Are Screaming Buys Right Now

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens

European Union Says Tariffs on U.S. Imports Will Kick In on June 22

European Union Says Tariffs on U.S. Imports Will Kick In on June 22

Stocks Rise, GE Dropped From the Dow, Starbucks, Oracle - 5 Things You Must Know

Stocks Rise, GE Dropped From the Dow, Starbucks, Oracle - 5 Things You Must Know

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge